National Survey Reveals Reactive Acne Treatment Persists, Despite Emotional Struggle Associated with Breakouts

FORT WORTH, Texas–(BUSINESS WIRE)–Galderma Laboratories, L.P. today announced results of a new national
survey that revealed more than 1,000 teens and young adults who have
experienced acne struggle emotionally with their breakouts, yet treat it
reactively and are anxious for results and effective acne treatments
without ever visiting a dermatologist or primary care physician (PCP).

“Acne can widely impact teens and young adults, especially on an
emotional level, yet many only treat their acne reactively and expect
immediate results,” said Dr. Dendy Engelman, NYC-based board-certified
dermatologist and Galderma consultant. “Acne sufferers have options,
including prescription treatment options for patients with acne ranging
from mild to moderate to severe inflammatory acne.”

A national survey* of more than 1,000 teens and young adult acne
sufferers revealed that:

  • Teens and young adults struggle emotionally and are quick to
    steer clear of cameras, mirrors, and social media –
    experiencing acne, 69% of teens and young adults have taken less
    pictures of themselves; many also avoid mirrors (40%), spend more time
    in their rooms (36%) and stay off social media (25%).1
    Specifically those with more severe acne have stayed off social media
    (46%) compared to mild and moderate sufferers (23%).2
  • Among teens and young adults, females tend to be more
    embarrassed about the acne they experience and are concerned about its
    – When experiencing acne, more girls than boys
    (74% vs. 58%) have avoided looking in the mirror.1
  • Despite this, 56% of teens and young adults only treat their
    acne with OTC products reactively and are impatient for OTC products
    to work right away
    1 – On average, results after
    using an OTC treatment are expected within three days; and 28% who are
    unsatisfied with results move on to another OTC option after a few
    weeks.1 Approximately half have jumped to using a new OTC
    acne product before finishing an old one and have even administered
    multiple OTC treatments on their skin at the same time.1
    For those experiencing more severe acne than usual, almost a third
    (31%) would be most likely to try an OTC treatment – fewer would
    prioritize a visit to a physician for a prescription (18%) or advice
  • Most teens and young adults are concerned about being able to
    find effective OTC treatment options –
    In fact, almost all
    (94%) would make sacrifices if it meant they’d never have acne again,
    including giving up Snapchat (57%) or Instagram (51%) for six months,
    wearing the same clothes as their friends (44%) and giving up dessert
    for a year (41%).1
  • Physicians, including dermatologists and PCPs, are rarely
    consulted for acne-related issues
    – More than 75% of teens and
    young adults report that they visit dermatologists less often than
    once a year, if ever.1 In fact, 44% of teens and young
    adults don’t know a PCP is able to provide them with a prescription
    for acne treatment.1

It’s important to recognize that if acne sufferers haven’t experienced
improvement within two weeks after using an OTC treatment, it may be
time to visit a physician to discuss prescription treatment options. One
option from Galderma includes Epiduo® Forte (adapalene and benzoyl
peroxide) Gel, 0.3%/2.5% that combines two antibiotic-free medicines in
one gel. Epiduo Forte Gel is the first combination of these strengths of
the retinoid, adapalene, and benzoyl peroxide, proven to help control
moderate to severe inflammatory acne. Another option from Galderma,
Epiduo (adapalene and benzoyl peroxide) Gel, 0.1%/2.5% is the #1
prescribed branded topical acne agent in the world, using two
antibiotic-free medicines for the treatment of acne. For patients with
mild to moderate acne, Epiduo Gel works to help treat current breakouts
quickly and help prevent future pimples from forming.

Important Safety Information

Indication: Epiduo® Forte (adapalene and benzoyl peroxide) Gel,
0.3%/2.5% is indicated for the topical treatment of acne vulgaris. Adverse
In the pivotal study, the most commonly reported adverse
reactions (≥1%) in patients treated with Epiduo Forte Gel were skin
irritation, eczema, atopic dermatitis and skin burning sensation. Warnings/Precautions:
Patients using Epiduo Forte Gel should avoid exposure to sunlight
and sunlamps and wear sunscreen when sun exposure cannot be avoided.
Erythema, scaling, dryness, stinging/burning, irritant and allergic
contact dermatitis may occur with use of Epiduo Forte Gel and may
necessitate discontinuation. When applying Epiduo Forte Gel, care should
be taken to avoid the eyes, lips and mucous membranes.

Important Safety Information

Indication: EPIDUO® Gel is indicated for the topical treatment of
acne vulgaris in patients 9 years of age and older. Adverse
 In controlled clinical studies, the most commonly reported
adverse events (≥1%) in patients treated with EPIDUO® Gel were dry skin,
contact dermatitis, application site burning, application site
irritation and skin irritation. Warnings/Precautions: Patients
taking EPIDUO® Gel should avoid exposure to sunlight and sunlamps and
wear sunscreen when sun exposure cannot be avoided. Erythema, scaling,
dryness, stinging/ burning, irritant and allergic contact dermatitis may
occur with use of EPIDUO® Gel and may necessitate

Additional information on Epiduo Forte Gel and Epiduo Gel can be found
in the prescribing information at

About Acne

Acne is the most common skin condition in the United States, affecting
more than 40 to 50 million people.3 Acne appears when pores
clog with dead skin cells,3 and can have a wide-ranging
negative impact on sufferers that includes both emotional and physical
scars.4 Studies show that many people who have acne suffer
from low self-esteem and depression,4 and that teens who
believe they have “bad” acne were more likely to think about hurting
themselves.4 Acne not only affects teenagers but also can be
seen in men and women of all ages3 with research showing that
the onset of acne is frequently seen in prepubescent patients.5

When it comes to acne treatment, long-term use of antibiotics may be a
contributing factor to the overall global antibiotic resistance issue.6
Propionibacterium acnes (P. acnes), a bacteria linked to acne, is
increasingly becoming resistant to topical and oral antibiotics,6
which may potentially cause a decrease in treatment efficacy against

About Galderma

Dating back to 1961, Galderma is now present in over 100 countries with
an extensive product portfolio to treat a range of dermatological
conditions. The company partners with health care professionals around
the world to meet the skin health needs of people throughout their
lifetime. Galderma is a leader in research and development of
scientifically-defined and medically-proven solutions for the skin, hair
and nails.

Strategic brands in the U.S. include Epiduo® Gel,
Epiduo® Forte Gel, Oracea® Capsules, Clobex®
Spray, Differin® Gel, Mirvaso® Gel, MetroGel®
Gel, Soolantra® Cream, Vectical® Cream, Tri-Luma®
Cream, Cetaphil®, Benzac® Acne Solutions, Restylane®,
Restylane® Silk, Restylane® Lyft, Dysport®
(abobotulinumtoxinA) and Sculptra® Aesthetic.

All trademarks are the property of their respective owners.

*The online survey, fielded in May 2015 among 1,000+ teens and young
adults 13-22 years of age who have had acne and tried at least one OTC
acne treatment, was developed by Galderma Laboratories, L.P with Kelton,
using an email invitation.

You are encouraged to report negative side effects of prescription drugs
to the FDA. Visit
or call 1-800-FDA-1088


  1. Kelton Global Research. Epiduo Break the Cycle Survey: NewsWorthy
    Analysis. June 2015.
  2. Kelton Global Research. Epiduo Break the Cycle Survey: Breakout
    Report. June 2015.
  3. American Academy of Dermatology. Acne: Who gets and causes.—d/acne/who-gets-causes.
    Accessed on October 12, 2015.
  4. American Academy of Dermatology. Acne.—d/acne.
    Accessed on October 12, 2015.
  5. Goldberg JL, et. al. Changing Age of Acne Vulgaris Visits: Another
    Sign of Earlier Puberty? Pediatr Dermatol. 2011
  6. Humphrey S. Antibiotic Resistance in Acne Treatment. Skin Therapy
    . 2012;17(9).
    Accessed on October 12, 2015.


Galderma North America
Virginie Naigeon
Director of Corporate
Brooke Shenkin, 212-301-7202